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Abstract
Glycogen particle is an intracellular organelle, which serves as a carbohydrate reserve in various cells. The function of glycogen
is not entirely known in several cell types. Glycogen can be mobilized for different purposes, which can be related to cellular
metabolic needs, intracellular redox state, metabolic state of the whole organism depending on regulatory aspects and also on cell
functions. Essentially there are two different ways of glycogen degradation localized in different cellular organelles: glycogen-
olysis or lysosomal breakdown by acid alpha-glucosidase. While glycogenolysis occurs in glycogen particles connected to
endoplasmic reticulum membrane, glycogen particles can be also combined with phagophores forming autophagosomes. A
subdomain of the endoplasmic reticulum membrane - omegasomes - are the sites for phagophore formation. Thus, three
organelles, the endoplasmic reticulum, the phagophore and the glycogen particle forms a triangle in which glycogen degradation
occurs. The physiological significance, molecular logic and regulation of the two different catabolic paths are summarized and
discussed with special aspect on the role of glycogen particles in intracellular organelle homeostasis and on molecular pathology
of the cell. Pathological aspects and some diseases connected to the two different degradation pathways of glycogen particles are
also detailed.
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Introduction
Mobilization of energy reserves or storage of energy intake are
fundamentally different states in metabolic regulation at cel-
lular level. They can be connected either to actual state of the
whole organism, but rather to actual metabolic conditions of
the cell [1]. However, these metabolic controls are also depen-
dent on cell types. Glycogen, as a branched polimer of glucose
is an important energy depot, therefore a possible source of the
immediate energy mobilization. Starvation is the most fre-
quent indication for mobilization of energy reserves. The
glycogen/tissue weight ratio is the highest in the liver. It is
well known that liver glycogen is essentially for glucose sup-
ply in starvation to maintain blood glucose level. The
glycogen/tissue weight ratio is smaller in skeletal muscle com-
pared to liver. Muscle glycogen is mobilized mainly to cover
energy needs of cells for muscle contraction. However, glyco-
gen can be found also in other tissues e.g. brain, erythrocytes,
but its quantity is less compared to liver and muscle and little
is known about its functions [1]. Nevertheless even neuronal
glycogen breakdown is connected to energy mobilization for
various cell specific purposes as learning, stress etc. [2].
Glycogen is not only a huge glucose store, but glycogen
particle is also a cellular organelle. In spite of the fact that
several moieties of glycogen molecule have been recognized
long time ago, it is noteworthy that some important facts
concerning on its functions, regulatory aspects and even cer-
tain constituents of the glycogen particle (e.g. glycogenin)
have been explored relatively lately [2] .
For the integration of metabolic homeostasis at cellular
level direct organelle-organelle connections are required.
Organelles, as separate metabolic compartments are connect-
ed to each other in different ways, among others by trans-
porters associated with integral membrane protein enzyme
complexes. Organelle interplay among the endoplasmic retic-
ulum (ER) and mitochondria is probably the most intensively
studied connection, which underlies cellular metabolic ho-
meostasis. Direct morphological and functional interactions
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for example between ER and mitochondria at membrane level
are well documented [3, 4]. The cross talk between ER and
mitochondria is mainly mediated by mitochondria-associated
membrane (MAM). Glycogen particles also participate in
organelle-organelle interactions. Previously we have already
published a hypothesis paper on physical and metabolic con-
nections among glycogen particles and ER in hepatocytes [5].
We suggested the term „glycogenoreticular system” for the
description of this functional coupling between the two organ-
elles. While recent proteomic data [6] confirm our hypothesis
on the importance of ER-glycogen particle connections, new
observations indicate a role of glycogen particles in autopha-
gy, which is also an important possibility for intracellular nu-
trient and energy mobilization. These recent findings have
focused attention to connection between glycogen particle
and lysosome besides its previously known connections with
ER (Fig. 1). Furthermore it turned out, that the two metabolic
ways of glycogen degradation – glycogenolysis and acidic
hydrolysis - and their different morphological localisations
may be also important aspects of intracellular metabolic ho-
meostasis. Recent advances in proteome analyses further con-
tribute to the current view on the role of glycogen particles in
intracellular metabolic integration. Our aim was to summarize
the morphological and functional interplay between glycogen
particles and cellular endomembrane system.
Glycogen Particles for Glucose Supply
to Intraluminal Formation of Various
Metabolites in the ER
ER is a metabolic compartment involved in a series of cellular
functions require direct connections with other organelles.
Mitochondria are often referred as „energy powerhouse” of
the cell, while ER has rather biosynthetic functions [7].
Molecules formed and matured in ER luminal compartment
are usually secreted to the extracellular space [8]. Several pre-
cursors for various ER products are originated from glycogen-
olysis. Demand for mobilization of certain metabolites secret-
ed from the ER are initiated by extracellular stimuli (e.g. de-
crease in blood glucose level in hepatocytes). But intracellular
metabolic conditions (e.g. altered redox homeostasis due to
enhanced mitochondrial metabolism in cardiomyocytes) may
also stimulate mobilization of cellular energy reserves.
Metabolism of liver glycogen is mainly controlled by extra-
cellular stimuli depending on the actual state of metabolism in
the organism, while mobilization of muscle glycogen stores is
controlled rather „inside” depending on the actual energetic
state of the muscle cell.
Less attention has been focused on connection among ER
and glycogen particles from the point of the maintenance of
various ER functions, while the connection is morphological-
ly proven [9, 10]. Glucose obviously is in the center of me-
tabolism both at the level of the organism and also at cellular
level. The basic role of blood glucose level in the maintenance
of metabolic homeostasis in mammals is related to its essential
function in intracellular metabolism. Glycogen particles are
participating in supply of several glucose derived metabolites
to maintain intracellular metabolic homeostasis, and the bulk
of these processes is localized in the ER.
Both glucose secretion and glucuronidation of endo- and
xenobiotics in second phase of biotransformation in the liver
are dependent on hepatic glycogen reserves [11, 12]. Thus,
physical proximity results in direct metabolic interactions
among glycogen particle and ER. A common character of

















Fig. 1 Degradation of glycogen
depends on organelle –
glycogen particle interactions.
Glycogenolysis results in glucose
formation, which is further
metabolized or secreted from the
cells depending also on the
localization of glycogen
berakdown. Glycogen particle
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they are mediated by combined enzyme – transporter systems,
and the active site of the corresponding enzymes is
intraluminal - glucose-6-phosphatase and UDP-glucuronosyl
transferases are the best known examples [13–16].
Moreover, ascorbate synthesis (when present) has been
shown to be connected to glycogenolysis in the hexuronic acid
pathway [17–19] in animals. Gulonolactone oxidase
catalysing the last step of ascorbate synthesis in this pathway
is expressed also in the ER membrane [20]. Furthermore, sev-
eral changes in intraluminal redox state are connected to gly-
cogenolysis. Fasting and glucose deprivation decrease the
NADPH/NADP redox ratio in the ER lumen via the reduced
substrate supply to hexose-6-phosphate dehydrogenase, the
main luminal NADPH generating enzyme [21, 22] et alet al.
It can be supposed that the formation of the carbohydrate
moiety of glycoproteins is also connected to glycogen re-
serves. All the above mentioned metabolic connections were
observed in hepatocytes, thus the glycogenoreticular system
can be the mechanistic base of a liver-specific metabolic
toolkit. Glycogenolysis in glycogen particles is under hor-
monal control or occurs upon various other stimuli, eg. xeno-
biotic exposition, intensive ROS formation. Therefore a direct
connection among glycogen particles and ER membranes in
the liver should be underlying these processes.
Analysis of hepatic glycogen proteome revealed that mito-
chondrial, peroxisomal, lysosomal and ER proteins are equal-
ly present, indicating that glycogen particle specifically inter-
acts with these organelles [6]. Interestingly, glycogen prote-
ome in adipocytes showed a complete absence of ER proteins
[23], which suggests that the association of glycogen particles
and ER membrane is a liver specific phenomenon [5].
Hepatic glycogen proteome of mice includes proteins that
mediate the subcellular localization of glycogen particles, such
as starch-binding domain-containing protein 1 (STBD1), which
contains both a transmembrane endoplasmic reticulum signal
peptide and a carbohydrate-binding domain [6].
Comparing to mouse, the rat glycogen proteome contains
even more ER-resident proteins, including cytochrome P450
proteins and UDP-glucuronosyltransferases that are involved
in biotransformation [6]. The physical proximity of these pro-
teins with glycogen particles validates the concept of the
glycogenoreticular system proposed by us earlier [5] and sup-
ports the observation that the glucose unit required for
glucuronidation is derived from glycogen and not gluconeo-
genesis or glucose uptake [11].
Degradation of Glycogen in Autophagosomes
It is well known that glycogen degradation – glycophagy -
occurs also in lysosomes (Fig. 1). Recent new observations
showed new, interorganelle: glycogen part icle –
autophagosome connections. These interactions are also serv-
ing glucose production for intracellular purposes.
Glycogen can be degraded to glucose by lysosomal or acid
alpha-glucosidase in the autophagosomes. Sequestration and
degradation of glycogen in the autophagosomes is a selective,
hormonally controlled and highly regulated process,
representing a mechanism of glucose homeostasis under con-
ditions of demand for the production of this sugar. Targeting
of glycogen into the autophagic pathway is governed by two
proteins. STBD1 binds glycogen in vitro and in vivo; it is
known to anchor glycogen to intracellular membranes [24].
STBD1 also interacts with GABARAPL1, one of the mam-
malian orthologs of Atg8, a protein implicated in
autophagosome membrane formation and closure in yeast.
The LC3-interacting region (LIR) motif of STBD1 binds to
GABARAPL1 [25]. This glycogen-specific form of
macroautophagy has been designated as glycophagy [24].
Glucose, the final pruduct of lysosomal glycogen hydroly-
sis, can leave the lumen of the autophagosomes via perme-
ases; spinster (Spin), a putative lysosomal efflux permease has
been postulated as a sugar transporter [26]. It was found that
the sugar transporter activity of Spin is essential for autopha-
gic lysosome reformation and mTOR reactivation following
starvation. Defects in spin led to the accumulation of enlarged
autolysosomes. Glucose released into the cytosol can be
reutilized in different metabolic pathways following its phos-
phorylation; alternatively, it can leave the cell contributing to
the elevation of blood glucose level.
The importance of glycophagy in the human metabolism
has not been revealed in all details. The process evidently has
crucial importance in newborns to combat neonatal hypogly-
cemia by glucagon dependent stimulation of the production of
non-phosphorylated glucose from glycogen [27–29]. Animal
models revealed that ATG5 and 7 knockout mice with defec-
tive autophagy could not survive the first day after birth [30,
31]. Accumulation of glycogen-containing vacuoles
(autophagosomes) was observed in the neighbourhood of gly-
cogen granules in the hepatocytes and cardiomyocytes of
newborn rats [32, 33].
On the other hand, insulin in the presence of high glucose
concentration also resulted in glycogen accumulation and the
elevation of glycophagy markers in cultured neonatal rat ven-
tricular myocytes [34]. Indeed, high intracellular glucose con-
centration was shown to induce autophagy [35]; the effect is
possibly mediated by glucose-6-phosphate via decreased
phosphorylation of mTOR and Akt.
The Role of the ER in Glycophagy
Although the localization of the phagophore biogenesis has
not been unequivocally clarified, the omegasomes of the ER
supposed to be a possible origin of phagophores [36]. With
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respect to glycophagy, two ER proteins seem to participate in
the early phase of autophagy. STBD1, which contains both a
transmembrane ER signal peptide and a carbohydrate-binding
domain [6] has also a LIR domain for binding Atg8-related
proteins, such as GABARAPL1 (see above). Thus, the protein
has a dual role: it can connect glycogen particle to the ER and
can behave as a cargo receptor for glycophagy. Furthermore,
the integral ER protein glucose-6-phosphate transporter
(G6PT) stimulates the initiation of autophagy by a mechanism
which is independent from its transporter activity [37]. G6PT
is known to be transcriptionally regulated by a cAMP depen-
dent manner [38], which can promote autophagy in starvation.
Pathological Implications
Mutations of the already known components of G6Pase sys-
tem are well characterized and they are known to cause the
different subtypes of glycogen storage disease type I (GSD I,
von Gierke disease) [39]. Gene defects in lysosomal alpha
glucosidase cause GSD type II, also known as Pompe disease,
a disorder with autosomal recessive inheritance. The defect of
autophagic glycogen degradation leads to the failure of pro-
ductive autophagy of glycogen in muscle cells. STBD1 could
target glycogen molecules for lysosomal recycling either as a
random housecleaning process or as part of a more directed
transport system. With regard to the latter proposition, it is
interesting that STBD1 binds better to plant amylopectin or
glycogen from Epm2a−/− mice. Both amylopectin and
Epm2a−/− glycogen are less branched than normal glycogen,
similar to the polyglucosans associated with other glycogen
storage diseases, including Andersen disease, Adult
polyglucosan disease seen in neurons, glia cells,
cardiomyocytes, and Tarui disease [2, 40]. Evidently, aber-
rantly branched glycogen in cells is to be avoided, and
STBD1 could selectively target such abnormal glycogen for
transport to lysosomes and for subsequent disposal. It is noted,
that STBD1 has higher affinity to structurally abnormal, e.g.
less branched glycogen [24]. Another example for
polyglucosans is the Lafora disease, where high number of
insoluble polyglucosan bodies (Lafora bodies) were shown
in neuronal cells [40] leading to chronic neurological diseases.
Galactosamine hepatitis is an experimental glycogen struc-
ture abnormality - functional loss example for the ER glyco-
gen particle interactions. In galactosamine- induced liver inju-
ry in rats and mice cytoplasmic aggregates containing glyco-
gen, ER membranes and ribosomes were found causing an
inhibition of hepatic protein synthesis [41]. Galactosamine
incorporated into glycogen causing a structural change, for-
mation of aminoglycogen, which led to formation of these
insoluble cytoplasmic bodies.
Autophagy and glycogenolysis compete for glycogen
breakdown in the liver. One should suppose a cross-
regulation ensuring glucose production in various metabolic
conditions, i.e. inhibition of autophagy should stimulate gly-
cogenolysis and vice versa. However, a recent study observed
impaired autophagy cultured cells, and animal models of GSD
type Ia. Both the stimulation of the anti-autophagic mTOR,
and inhibition of the pro-autophagic AMPK pathways were
present in various models in vitro and in vivo. Stimulation of
autophagy by agents downstream of mTOR and AMPK
(ULK1/ATG1 overexpression and rapamycin treatment) de-
creased hepatic triglyceride and glycogen content in G6PC(−/
−) mice [42]. The results clearly indicate autophagy could
partially compensate the metabolic changes in GSD1a, but
its inhibion prevents the potential ameliorative effects.
Similarly, when autophagy was blocked, the level of
glucose-6-phosphatase was reduced in HepG2 cells [43].
Further studies are needed to clarify these virtually conflicting
observations, which can be connected to the different func-
tions of autophagy.
Implications in Tumors
Recycling of macromolecules is a requirement that is particu-
larly important in the tumor microenvironment characterized
by low glucose (nutrient?) concentration, hypoxia and acido-
sis [44]. Glycogen has been reported to be present in different
tumor cell lines of various origins in high quantity [45].
However, glycogen metabolism has not been fully elucidated
in tumor cells. It can be hypothesized that glycophagy, as a
type of autophagy contributes significantly to glycogen
recycling in tumors. Tumor cells can have upregulated au-
tophagy [46, 47]; recent findings underline the pro-survival
role of autophagy in cellular decision-making processes be-
tween life and death both in normal and tumor cells [48, 49].
The demonstration of involvement of glycophagy in the pro-
survival effects needs further investigations. These findings
suggest that inhibition of the autophagy may threaten tumor
survival via metabolic effects, which may open a new ap-
proach for cancer therapy [50]. In line with this assumption,
combination of caloric restriction with the deficiency in au-
tophagy promotes cell death in tumors [51].
Conclusions
Glucose is in the focus of metabolism at cellular and multicel-
lular level for obvious reasons: regulation of blood glucose
concentration, glucose is the only food molecule for every cell
types etc. Mobilization of intracellular energy reserves is a
prompt demand upon various stimuli and glycogen particles
are essential glucose sources in this sequence of events.
Interactions of glycogen particles with the ER or with lyso-
somes are regulated processes in this organized cellular
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response and all the aspects of selections among these two
different routes have not yet explored. It is noted that the liver
seems to be unique, as hepatocytes have the full genomic
„kit”, which makes possible to perform all kinds of metabolic
pathways.
Glycogen degradation has been associated to the energy
mobilization in cells for various purposes to different stimuli
depending on the cell types. New data on autophagy need a
major change in interpretation concerning biological roles of
glycogen particles. This progress is also connected on the
newly discovered forms of autophagy, as lipophagy and
glycophagy, and their relations to the general regulation of
cellular growth as mTOR and AMPK. The use of glycogen
stores for glucose specific and less glucose specific purposes
can be also underlying between the choices of the ways of
glycogen degradation. It is noteworthy that from the points
of structure-function-metabolism connections macromole-
cules having altered structures – glycogen, proteins - usually
are eliminated by autophagy [52]. On the other hand a com-
prehensive view on organelle-glycogen particle interactions is
also hampered by the relatively limited knowledge on glyco-
gen functions in various other cell types different from hepa-
tocytes and skeletal muscle cells.
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